KPTI: SEC Form SC 13G filed by Karyopharm Therapeutics Inc.
Stocks in this Quantisnow insightHealth Care
Keep researching KPTI
- What is Schedule 13G?A short-form SEC disclosure for investors who own more than 5% of a company's voting stock but hold it passively, without intent to influence control.
- Schedule 13D vs 13GSchedule 13D vs 13G explained: who must file when crossing 5% ownership, the 2024 deadlines, how activists differ from passive holders, and what Item 4 reveals.
- KPTI insider tradesEvery buy and sale reported by Karyopharm Therapeutics Inc. officers, directors and large holders.
- KPTI earnings historyPast Karyopharm Therapeutics Inc. earnings releases, newest first.
- KPTI financial statementsRevenue, profit, cash flow and balance sheet from Karyopharm Therapeutics Inc.'s SEC filings.
Quantisnow market dataNASDAQ
KPTI
Karyopharm Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2013
Get push alerts for KPTI
Full KPTI profile on Quantisnow Follow KPTI and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time